ADP-ribose-acceptor hydrolase 2 (Arh2) deficiency results in cardiac dysfunction, tumorigenesis, inflammation, and decreased survival
J. Kato, S. Yamashita, H. Ishiwata-Endo, S. Oka, Z.-X. Yu, C. Liu, D. Springer, A. Noguchi, M. Peiravi, V. Hoffmann, M. J. Lizak, M. Medearis, I.-K. Kim, J. Moss
This study shows that Arh2 deficiency leads to cardiac dysfunction, tumorigenesis, inflammation, and reduced survival in mice.
bioRxiv · Feb 7, 2023 · PreprintCancer Biology